{"transactions":[{"id":4638347,"issuer":{"id":184308,"kind":"organization","name":"TRex Bio, Inc.","symbol":"TRXB"},"owners":[{"id":65666,"kind":"person","name":"Coy Travis Alan","position":1,"cik":"0001969524","reported_name":"Coy Travis Alan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-10-09T01:53:11.000Z","date":"2026-10-08","kind":"grant","planned":false,"acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on October 8, 2027, subject to the reporting person's continued service through such date."}],"balance_after":17500,"derivative":{"exercise_price":14,"expiration_date":"2036-10-08","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001193125-26-418298","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2139097/000119312526418298/ownership.xml","form_type":"4"}},{"id":893383,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":65666,"kind":"person","name":"Coy Travis Alan","position":1,"cik":"0001969524","reported_name":"Coy Travis Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Share Option (Right to Buy)","published_at":"2026-02-19T22:00:28.000Z","date":"2026-02-17","kind":"grant","planned":false,"acquired":true,"shares":95637,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to the option award shall vest on February 17, 2027, and 6.25% of the shares subject to the option award shall vest in quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"Ordinary Shares may be represented by American Depositary Shares.  Each American Depositary Share represents one Ordinary Share."}],"balance_after":95637,"derivative":{"exercise_price":32.38,"expiration_date":"2036-02-16","underlying":"Ordinary Shares","underlying_shares":95637},"source":{"system":"sec-edgar","filing":"0001969524-26-000002","document":"form4-02192026_100225.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000196952426000002/form4-02192026_100225.xml","form_type":"4"}},{"id":893382,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":65666,"kind":"person","name":"Coy Travis Alan","position":1,"cik":"0001969524","reported_name":"Coy Travis Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Share Units","published_at":"2026-02-19T22:00:28.000Z","date":"2026-02-17","kind":"grant","planned":false,"acquired":true,"shares":33353,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit (\"RSU\") represents a contingent right to receive one Ordinary Share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in four equal annual installments beginning February 17, 2027, subject to the Reporting Person's continuous service through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in four equal annual installments beginning February 17, 2027, subject to the Reporting Person's continuous service through each such vesting date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"Ordinary Shares may be represented by American Depositary Shares.  Each American Depositary Share represents one Ordinary Share."}],"balance_after":33353,"derivative":{"underlying":"Ordinary Shares","underlying_shares":33353},"source":{"system":"sec-edgar","filing":"0001969524-26-000002","document":"form4-02192026_100225.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000196952426000002/form4-02192026_100225.xml","form_type":"4"}},{"id":1314771,"issuer":{"id":4544,"kind":"organization","name":"Immunocore Holdings plc"},"owners":[{"id":65666,"kind":"person","name":"Coy Travis Alan","position":1,"cik":"0001969524","reported_name":"Coy Travis Alan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Share Option (Right to Buy)","published_at":"2025-01-03T21:08:28.000Z","date":"2025-01-01","kind":"grant","planned":false,"acquired":true,"shares":274033,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option award shall vest on January 1, 2026, and 6.25% of the shares subject to the option award shall vest in quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":274033,"derivative":{"exercise_price":29.5,"expiration_date":"2034-12-31","underlying":"Ordinary Shares","underlying_shares":274033},"source":{"system":"sec-edgar","filing":"0001415889-25-000390","document":"form4-01032025_090124.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671927/000141588925000390/form4-01032025_090124.xml","form_type":"4"}}]}